Michael Schlappa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michael Schlappa has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Axel Schmid
Friedrich-Alexander-University of Erlangen-Nuremberg, Institute of Radiology, University Hospital Erlangen, Erlangen, Germany
1 shared publication Jürgen Siebler
Department of Medicine 1, University hospital, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
1 shared publicationMichael Uder
Institute of Radiology, University Hospital, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
1 shared publicationRobert Grützmann
Department of Surgery, University Hospital, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
1 shared publicationWolfgang Wüst
Institute of Radiology, Martha-Maria Hospital Nürnberg, Nuremberg, Germany
1 shared publication
Latest Publications
- Open Access
- 6 July 2022
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 45 (9) , 1401-1407
Efficacy and Safety of Angioplasty Balloon Interposition in CT-Guided Percutaneous Thermal Ablation of Hepatic Malignancies to Protect Adjacent Organs
Purpose: To evaluate the feasibility and safety of placing angioplasty balloons between the liver surface and adjacent organs in CT-guided thermal ablation of subcapsular liver malignancies in case of inadequate success of conventional dissection techniques. Materials and Methods: A retrospective, single-centre database query identified 327 hepatic malignancies in 153 patients treated in 215 sessions from 2016 to 2018 by thermal ablation. Demographic data, tumour size, distance to adjacent structures, complications and long-term outcomes were assessed when ancillary procedures were performed to protect adjacent organs. Results: In 21 of 327 (6.4%) ablations, thermal protection was necessary. Balloon interposition was successfully performed in 9 cases in 8 patients after hydrodissection or gas insufflation failed to separate adherent organs. Median pre- and post-balloon insertion distance was 0 mm [0–2 mm] and 17 mm [8–20 mm]. No balloons were damaged, ruptured or slid away from their initial position. Technical success of MWA and protection of adherent structures were achieved in all procedures. In a median follow-up of 11.5 months [0–49 months], the local control rate was 88.9% as 1 patient was treated twice with an interval of 3 months for local recurrence. Three non-process-related major complications and 1 minor complication occurred. Conclusion: Balloon interposition is a safe and feasible method to enable thermal ablation to a greater number of patients, even after established thermo-protective techniques fail to separate the colon or stomach from the liver surface.
- 6 July 2022
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 45 (9) , 1401-1407
Open AccessEfficacy and Safety of Angioplasty Balloon Interposition in CT-Guided Percutaneous Thermal Ablation of Hepatic Malignancies to Protect Adjacent Organs
Purpose: To evaluate the feasibility and safety of placing angioplasty balloons between the liver surface and adjacent organs in CT-guided thermal ablation of subcapsular liver malignancies in case of inadequate success of conventional dissection techniques. Materials and Methods: A retrospective, single-centre database query identified 327 hepatic malignancies in 153 patients treated in 215 sessions from 2016 to 2018 by thermal ablation. Demographic data, tumour size, distance to adjacent structures, complications and long-term outcomes were assessed when ancillary procedures were performed to protect adjacent organs. Results: In 21 of 327 (6.4%) ablations, thermal protection was necessary. Balloon interposition was successfully performed in 9 cases in 8 patients after hydrodissection or gas insufflation failed to separate adherent organs. Median pre- and post-balloon insertion distance was 0 mm [0–2 mm] and 17 mm [8–20 mm]. No balloons were damaged, ruptured or slid away from their initial position. Technical success of MWA and protection of adherent structures were achieved in all procedures. In a median follow-up of 11.5 months [0–49 months], the local control rate was 88.9% as 1 patient was treated twice with an interval of 3 months for local recurrence. Three non-process-related major complications and 1 minor complication occurred. Conclusion: Balloon interposition is a safe and feasible method to enable thermal ablation to a greater number of patients, even after established thermo-protective techniques fail to separate the colon or stomach from the liver surface.